Lampropoulos Fred P. 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Nov 20, 2025

Form 4

Period: 2025-11-18

DirectorPresident & CEO

Transactions

Sale
Common Stock, No Par Value
2025-11-18$84.83/sh−5,000$424,130→ 1,074,955 total

Holdings

Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (54,302 underlying)
54,302
Common Stock, No Par Value
(indirect: By Spouse)
8,280.258
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (58,083 underlying)
58,083
Common Stock, No Par Value
(indirect: By 401(k))
98,132
Common Stock, No Par Value
(indirect: By Spouse)
90
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (100,334 underlying)
100,334

Footnotes (6)

[F1]Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
[F2]The 401(k) number represents plan holdings as of 10/31/2025.
[F3]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.03 to $86.44, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F4]Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
[F5]Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
[F6]Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.

Documents

1 file